BSX - Company ID 0000885725
The table below shows BOSTON SCIENTIFIC CORP's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $5.20B | $5.07B | $5.06B | $4.66B | $4.21B | $4.12B |
| Cost of revenue | $1.59B | $1.52B | $1.64B | $1.45B | $1.31B | $1.27B |
| Gross profit | $3.61B | $3.54B | $3.42B | $3.21B | $2.90B | $2.85B |
| R&D | - | - | - | - | - | - |
BOSTON SCIENTIFIC CORP reported annual revenue of $20.07B for fiscal year 2025. That is up 19.9% from $16.75B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $9.08B (FY 2016) to $20.07B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $1.78B |
| $1.74B |
| $1.72B |
| $1.60B |
| $1.56B |
| $1.45B |
| Operating income | $1.10B | $1.05B | $819.00M | $921.00M | $733.00M | $520.00M |
| Income tax | -$176.00M | $183.00M | $146.00M | $133.00M | $200.00M | $98.00M |
| Net income | - | - | - | - | - | - |
| EPS (diluted) | $0.90 | $0.51 | $0.53 | $0.45 | $0.32 | $0.22 |